Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Maximally efficient two-stage screening.

Berger T, Mandell JW, Subrahmanya P.

Biometrics. 2000 Sep;56(3):833-40.

PMID:
10985223
2.

Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.

Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G.

Health Technol Assess. 2001;5(33):1-56. Review.

3.

Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.

Kirkland DJ, Henderson L, Marzin D, Müller L, Parry JM, Speit G, Tweats DJ, Williams GM.

Mutat Res. 2005 Dec 30;588(2):88-105. Epub 2005 Dec 2. Review.

PMID:
16326131
4.
5.

[Problems and limitations of conventional and innovative methods for the diagnosis of Toxoplasmosis in humans and animals].

Piergili Fioretti D.

Parassitologia. 2004 Jun;46(1-2):177-81. Review. Italian.

PMID:
15305712
6.

Screening for type 2 diabetes.

Engelgau MM, Narayan KM, Herman WH.

Diabetes Care. 2000 Oct;23(10):1563-80. Review. Erratum in: Diabetes Care 2000 Dec;23(12):1868-9.

7.

Biostatistical methods for the validation of alternative methods for in vitro toxicity testing.

Edler L, Ittrich C.

Altern Lab Anim. 2003 Jun;31 Suppl 1:5-41. Review.

PMID:
15595899
8.

[Traditional and innovative diagnostic tools: when and why they should be applied].

Cancrini G, Iori A.

Parassitologia. 2004 Jun;46(1-2):173-6. Review. Italian.

PMID:
15305711

Supplemental Content

Support Center